title: Immunogenicity and tolerability of hepatitis A vaccine in HIV-infected children.
abstract: The immunogenicity and tolerability of hepatitis A virus vaccine was evaluated in a group of 32 children with human immunodeficiency virus (HIV) infection and 27 children with seroreversion. After 2 doses of vaccine, 100% of children experienced seroconversion with good toleration of the vaccine. There were no differences in variation of virus load between immunized HIV-positive children and a group of 31 nonimmunized HIV-positive children with similar characteristics.
authors: Division of Pediatric Infectious Diseases, Federal University of São Paulo, São Paulo, Brazil.
authors: A F T B
authors: AF
authors: Gouvea
authors: M I
authors: MI
authors: De Moraes-Pinto
authors: E
authors: E
authors: Ono
authors: M I S
authors: MI
authors: Dinelli
authors: D M
authors: DM
authors: Machado
authors: L Y
authors: LY
authors: Weckx
authors: R C M
authors: RC
authors: Succi
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D002648:Child; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology*; D035922:Hepatitis A Antibodies / Q000096:biosynthesis* / Q000097:blood; D022362:Hepatitis A Vaccines / Q000008:administration & dosage / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance
chemical_list: D035922:Hepatitis A Antibodies; D022362:Hepatitis A Vaccines